WebSify
Follow us on
Mail
Print

Summary Box: FDA expands approval of J&J drug

Source : AP
Last Updated: Mon, Dec 10, 2012 21:00 hrs

FDA OK: The Food and Drug Administration on Monday approved the drug Zytiga for a new group of prostate cancer patients who have not yet received chemotherapy.

FAMILIAR FACE: The FDA previously approved the pill from Johnson & Johnson for men with prostate cancer who have already taken the chemotherapy drug docetaxel.

HALTING HORMONES: Zytiga works be decreasing the male hormone testosterone, which spurs growth of prostate tumors.


blog comments powered by Disqus
most popular on facebook
talking point on sify finance